Ironwood Pharmaceuticals | IRWD - Acreedores Comerciales

Precio De Mercado
3.06
Cambio Diario
-0.09 -2.86%
Mensual
-14.29%
Anual
117.02%
Q1 Expectativa
2.97




Acreedores Comerciales Cambio Fecha
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
Akebia Therapeutics USD 21.18M 11.1M 2025-12
Almirall EUR 258.05M 58.66M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Amarin USD 45.36M 8.64M 2025-12
Ardelyx USD 19.24M 845K 2025-12
Astellas Pharma JPY 181.95B 13.3B 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Charles River Laboratories USD 148.8M 20.82M 2025-12
Coherus Biosciences USD 9.91M 14.98M 2025-12
Emergent BioSolutions USD 112.2M 500K 2023-12
Esperion Therapeutics USD 65.07M 12.44M 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Incyte USD 1.63B 1.46B 2025-12
Ironwood Pharmaceuticals USD 1.61M 224K 2025-09
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
Lexicon Pharmaceuticals USD 3.08M 714K 2025-12
MacroGenics USD 4.79M 1.15M 2025-12
Moderna USD 317M 50M 2025-12
Myriad Genetics USD 30M 1.8M 2025-12
Pacira USD 15.15M 2.54M 2025-12
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Takeda JPY 467.59B 28.61B 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12